Quality By Design: The Highest-Standard Approach To Process Validation For Early And Late-Stage Projects
Source: AGC Biologics

The challenge here was to develop and validate manufacturing processes for two novel molecules, one in phase 1 development and the other in phase 3.
AGC Biologics is committed to providing its clients with Quality by Design, an approach to Process Development based on formalized methods and Quality System infrastructure that simultaneously support at-scale manufacturing for early-phase clinical trials and scale-up to meet late-phase clinical and commercial needs.
VIEW THE CASE STUDY!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.
Subscribe to Outsourced Pharma
X
Subscribe to Outsourced Pharma
AGC Biologics
This website uses cookies to ensure you get the best experience on our website. Learn more